SplitJul 31, 2026, 04:24 PM
NeuroSense Shareholders to Vote on Reverse Share Split
AI Summary
NeuroSense Therapeutics Ltd. will hold a Special General Meeting of Shareholders on August 26, 2026, to vote on a proposal to effect one or more reverse share splits. The proposed ratio range is 1 for 4 to 1 for 40, with the exact ratio and effective date to be determined by the Board within 12 months. This action is intended to help the company regain compliance with Nasdaq's minimum bid price and market value of listed securities requirements to avoid delisting. The Board unanimously recommends shareholders approve the proposal.
Key Highlights
- Special General Meeting of Shareholders scheduled for August 26, 2026.
- Shareholders to vote on a reverse share split at a ratio of 1 for 4 to 1 for 40.
- Board of Directors to determine exact ratio and effective date within 12 months.
- Purpose is to regain compliance with Nasdaq's $1.00 minimum bid price and $35M market value requirements.
- Record date for voting is July 31, 2026.
- Board unanimously recommends voting in favor of the proposal.
- Company had 37,766,098 ordinary shares outstanding as of July 29, 2026.
Price Impact
More from NRSN